Objective: Type II endoleak after endovascular aneurysm repair (EVAR) is frequently caused by persistent flow from the inferior mesenteric artery (IMA). The aim of this study was to assess the perioperative and midterm efficacy of laparoscopic ligation of the IMA for treatment of endoleak.
Evolution in endovascular techniques and devices as well as improvement of operators' expertise has resulted in better outcomes of endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). 1 During the last decades, although EVAR has emerged as the treatment of choice, 2, 3 it has been recognized that it may be associated with several adverse outcomes, such as endoleak and endograft occlusion. Thus, reintervention rates remain high, and long-term follow-up is recommended in contrast to open repair for AAA. 2, 3 Lifelong surveillance still appears mandatory, and computed tomography angiography is the most widely used imaging modality. 4 Type II endoleak, a relatively common finding diagnosed after EVAR, 5, 6 is caused by retrograde collateral blood flow into the aneurysmal sac from patent aortic side branches, such as the inferior mesenteric artery (IMA), lumbar arteries, or median sacral artery. 7 Although type II endoleak may spontaneously seal over time, persistence may risk aneurysm sac enlargement, need of reintervention, or even aortic rupture. 8, 9 Persistent flow from the IMA to the aneurysm sac after EVAR is present in 45% to 85% of all type II endoleaks. [10] [11] [12] Postoperative strategies to embolize the IMA and thereby to treat type II endoleaks have been described. Traditionally, the transarterial technique involves selective embolization of the IMA (through the middle colic artery). 13, 14 In recent studies, though, it has been suggested that IMA embolization has a high rate of treatment failure. 15, 16 Alternative strategies to treat type II endoleak consist of translumbar and transcaval embolization. 13, 17 Another treatment option is video laparoscopic surgery with clipping or ligation at the origin of the IMA. Some of the potential advantages of this technique compared with other treatment modalities may be the use in patients with chronic renal insufficiency (no contrast agent is used) and as an alternative option in unsuccessful endovascular interventions, absence of radiation, and potentially less artifact in future procedures. This technique is so far used only in specialized centers and has not been widely applied.
The aim of this study was to identify such cases in the literature and to assess the midterm efficacy and safety of post-EVAR laparoscopic ligation of the IMA for treatment of type II endoleak.
METHODOLOGY
Search strategy. An electronic search of the literature was undertaken using the databases MEDLINE (database provider PubMed), Embase (database provider Ovid), and Cochrane Central Register of Controlled Trials. The PICO (patient, intervention, comparison, outcome) model (Table I ) was used to better define the clinical questions and to find the clinically relevant evidence in the literature. 18 Every included study had only one major eligibility criterion: to report on laparoscopic ligation of the IMA for treatment of type II endoleak after EVAR. A further search including manual screening of the reference lists of selected articles identified through the electronic search was undertaken. English was the only language of the articles chosen for review. To identify relevant studies, the following search terms were combined in the expanded Medical Subject Headings and keyword searches: "laparoscopic ligation" or "endoleak type II" and "endovascular repair." A primary selection of relevant studies was based on the title and abstract; a secondary selection was performed according to the full text of publications.
Study selection. All articles located in the initial search strategy had their abstracts and titles independently screened by two authors (K.S. and N.T.), and any discrepancies were resolved after consensus with discussion between K.S. and N.T. and a third senior author (T.K.). Selected abstracts were subsequently reviewed to see whether they met the eligibility criterion. To avoid the inclusion of duplicate publications of the same data, the data were examined for similarities (eg, identical start and end dates), and if necessary, the authors were contacted for clarification.
Extraction of data. A standardized data extraction Excel file (Microsoft, Redmond, Wash) was developed; data were retrieved only from the text and tables, and no attempt was made to obtain missing data from the authors. Data included the characteristics of the studies, such as journal type, date of publication, variability of study group, and treatment. Also recorded were demographics (age, sex); mean AAA diameter; time of the intervention; mean hospital time; warfarin administration; and comorbidities of each patient, such as hypertension, hyperlipidemia, diabetes mellitus, coronary artery disease, renal insufficiency, obesity, and chronic obstructive pulmonary disease. Data regarding the duration of the operation, laparoscopic technique, any additional procedure, and blood loss during the operation were also recorded. Technical success rate, 30-day mortality, survival rates, and AAA diameter during follow-up were analyzed. Postoperative complications, such as open conversion, persisting endoleak (type II), and reintervention, were recorded.
The systematic review protocol, selection process, and reporting were based on the 2009 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 19 
(Fig).
Statistical analysis. Only descriptive data are presented because this PRISMA systematic review is not comparative, and only case reports and one retrospective cohort study were identified.
RESULTS
The flow chart of the selection process according to PRISMA is displayed in the Fig. Eight studies were case studies and one was a retrospective cohort study. The total number of patients included in these studies was 20 patients who underwent laparoscopic ligation of the IMA after endovascular repair because of persistent type II endoleak during 2000 to 2015.
The mean age of the patients was 73.6 6 2 years (90% [18/20] male); mean AAA diameter at the time of video laparoscopic surgery was 64.3 6 10 mm. Three of the patients were obese (body mass index >30); demographic data and comorbidities are displayed in Table II . The mean time until intervention after EVAR ranged from 6 to 18 months. All but one patient were asymptomatic; one patient presented with abdominal pain and was operated on emergently. In 9 patients, the aneurysm sac was enlarged in comparison to preprocedural AAA diameter (>5 mm during 6 months or >1 cm from the preoperative diameter); in 11 patients, although the sac diameter remained stable, the endoleak was considered persistent, and at the discretion of the treating physician, it was decided to be treated.
Procedural details and early (30-day) outcomes. In general, video laparoscopic ligation was applied in patients with no hostile abdomen (more than two major abdominal operations), with no inflammatory AAA, or with severe cardiac risk factors. Laparoscopic ligation of the IMA was performed through a transperitoneal route in all cases under general anesthesia. The number and size of the trocars used are displayed in Table III . In most cases, three trocars were introduced, with 10 mm the most common profile. Pneumoperitoneum was established using an open insertion with a blunt 10-mm trocar at the umbilicus. Another operating port was used at the level of the xiphoid process, with an additional port in the right iliac fossa. In one case, the da Vinci robotic system (Intuitive Surgical, Sunnyvale, Calif) was used. In all cases, the IMA was dissected from its origin at the aneurysmal sac, distal to the takeoff branch of the left colic artery, and nonabsorbable hemoclips were used to secure the ligation of the IMA, with attention paid not to damage the lower hypogastric plexus that runs close to the aortic tissue at this level. In four patients, additional procedures were undertaken: in one, simultaneous ligation of the right internal iliac artery (intraoperative angiography revealed that the type II endoleak was caused by continued retrograde flow originating from the IMA and exiting through the right internal iliac artery); in another one, ligation of lumbar arteries plus intrasac thrombin injection (because of the large numbers of lumbar arteries); in another one, a failed coiling of the IMA; and in the remaining one, intrasac thrombin injection (a planned one-stage laparoscopic IMA division with intrasac thrombin injection under direct laparoscopic vision and fluoroscopy).
The mean duration of the procedures was 99 6 24 minutes, with no relevant blood loss or need for transfusion. IMA ligation was confirmed intraoperatively with digital subtraction angiography or postoperatively with ultrasound or computed tomography angiography (Table IV) . The technical success rate was 90% (18/20) . Two initially unsuccessful cases were reoperated on within 24 hours after the first procedure (another arterial branch was ligated), and both laparoscopic revisions were successful. The reason for reoperation was misidentification of the IMA during the primary procedure. The mean hospital stay was 3.6 6 1.2 days. The perioperative and 30-day mortality rate was 0% (0/20). No patient presented with colon ischemia or required open conversion.
Follow-up outcomes. The mean follow-up was 32.6 6 12 months. In 65% of the patients (13/20), the aneurysmal sac regressed in comparison to preoperative measurements (the mean sac regression was from 60 to 55 mm in 11 patients and from 55 to 50 mm in 2 patients); in the rest of the patients, the sac diameter was considered stable. During follow-up, of the nine patients who were initially treated for aneurysmal sac enlargement, four had sac regression and four had stable sac diameter; in one, there was no record. Of the 11 patients who had initially been treated although their sac diameter was stable, 9 had a mean sac regression and 1 had a stable sac; in 1, there was no record. Open conversion or endovascular reintervention for type II endoleak was not reported in any of these patients. No IMA-related type II endoleak was identified during follow-up. One case with type II endoleak from lumbar arteries (120 months after 
DISCUSSION
The natural history of type II endoleaks is still poorly understood, and their management remains a controversial issue. Jones et al 29 reported that persistent type II endoleak is associated with an increased incidence of adverse outcomes, including aneurysmal sac growth, need for conversion to open repair, reintervention, and rupture, whereas Wyss et al found a significant association between sac expansion and rupture after EVAR. 30 On the other hand, Sidloff et al, 31 in a systematic review, reported that rupture after EVAR secondary to an isolated type II endoleak is rare (<1%). However, more than a third of rupture cases after EVAR occur in the absence of sac expansion. 31 Translumbar access and transcaval access for embolization are alternative strategies to treat type II endoleak, demonstrating high success rate and low risk of complications. 13, 17 In contrast, laparoscopic intervention for the treatment of type II endoleak has not gained recognition as a therapeutic option so far. One potential reason is that only a few vascular surgeons are trained to undertake this procedure, and thus collaboration with a general surgeon may be needed. 20 However, in a systematic review, the outcomes from selected patients in selected centers demonstrated that even elective laparoscopic repair of aortic aneurysms is a feasible and safe treatment entity. 32 Even more advanced laparoscopic techniques have been developed, such as laparoscopic sac fenestration for the treatment of postimplantation aneurysm growth. 33 Current guidelines recommend intervention in patients with type II endoleak when the sac diameter increases >10 mm during follow-up. 4 However, alternative intervention strategies at a lower threshold of 5 mm of growth have been reported as well as in cases with type II endoleak persistence without sac enlargement after 3 and 6 months. 34 According to the latter report, in this study, 9 patients had an expansion of the aneurysmal sac, whereas in 11, the endoleak was considered only persistent without sac enlargement. It has been suggested that early change in sac diameter is a strong predictor of late outcome after EVAR. 35 One report suggested that IMA type II endoleak after EVAR may be predictable. 11 Thus, the incidence of IMA type II endoleaks was associated with a larger crosssectional area of the aortic lumen at the level of the IMA ostium before EVAR (P ¼ .001). It was suggested that selection of a patient for protective preoperative IMA embolization might even be feasible. 12 Kray et al 36 had also reported that a preoperatively patent IMA was associated with increased rates of type II endoleak and AAA sac expansion, suggesting that consideration should be given to preoperative occlusion of a patent IMA Results showed a high technical success rate and no signs of colon ischemia. After a mean follow-up of 32.6 6 12 months, no recurrent IMA-related type II endoleak was identified. In 65% of patients, the aneurysm sac had regressed in comparison to preoperative measurements, and in the rest of the patients, the sac diameter was stable. This is an important fact as it has been shown that patients with major sac shrinkage have a very low risk of complications for up to 5 years. 35 The main limitation of our study was the low quality of the data because only case reports and one case cohort study exist in the literature. In addition, as these cases were executed in selected centers with profound laparoscopic expertise, the results with this method may not be generalized in daily practice. Although interventional techniques are currently the first choice in occluding the IMA artery that contributes to type II endoleak and sac expansion, laparoscopic ligation may continue to play a role in specialized centers treating selective patients, such as those with renal insufficiency (no contrast agent during laparoscopic procedure) or previous unsuccessful endovascular intervention. Our review shows that in centers with laparoscopic expertise, it appears to be efficacious and safe in the treatment of IMA-related type II endoleak, increasing the available options in the armamentarium of current endovascular practice.
CONCLUSIONS
Laparoscopic ligation of the IMA for treatment of type II endoleak after EVAR is a feasible and safe technique in specialized centers with high technical success rate and good midterm outcomes. 
AUTHOR CONTRIBUTIONS

